| Literature DB >> 34447522 |
Amel Mohamed Saleh1, Ahmed Omer Almobarak2, Safaa Badi3, Samar B Siddiq4, Hanan Tahir1, Mohamed Suliman5, Mohamed H Ahmed6.
Abstract
BACKGROUND: Prediabetes is an important stage before diabetes that can be treated with intensive lifestyle changes. The aim of this study was to assess knowledge, attitudes, and practice of primary care physician in Sudan about prediabetes.Entities:
Keywords: Attitude; Sudan; knowledge; practice; prediabetes
Year: 2021 PMID: 34447522 PMCID: PMC8356950 DOI: 10.4103/ijpvm.IJPVM_164_20
Source DB: PubMed Journal: Int J Prev Med ISSN: 2008-7802
Demographic characteristics of the participants (n=189)
| Demographics | Responses | % |
|---|---|---|
| Gender | Males | 21 |
| Females | 79 | |
| Qualifications | Family medicine MD | 1.6 |
| Family medicine MSc | 51.9 | |
| Family medicine registrar | 33.9 | |
| General Practionner | 12.7 | |
| worked abroad for a while | Yes | 42 |
| No | 58 | |
| Attended relevant courses dealing with prediabetes | Yes | 63.5 |
| No | 36.5 |
The distribution of study participants by knowledge towards prediabetes (n=189)
| Knowledge questions | Correct response |
| % |
|---|---|---|---|
| 1. Correct identification of prediabetes laboratory criteria | 2-h oral glucose tolerance test | 15 | 7.9 |
| fasting glucose | 89 | 47.1 | |
| HbA1c* | 81 | 42.9 | |
| Non-fasting glucose | 4 | 2.1 | |
| 2. What is fasting glucose cutoff indicative of prediabetes? | ≤125mg/dl* | 156 | 82.5 |
| Others | 33 | 17.5 | |
| 3. What is HbA1c cutoff indicative of prediabetes? | ≤6.4%* | 107 | 56.6 |
| Others | 82 | 43.4 | |
| 4-What proportion of their starting weight it is recommended that prediabetics lose? | ≥5% * | 143 | 75.7 |
| Others | 46 | 24.3 | |
| 5. Recommended physical exercise per week | 150 mins* | 98 | 51.9 |
| Others | 91 | 48.1 | |
| 6. How often do patients return for follow-up clinic visit? | Annually* | 10 | 5.3 |
| Others | 179 | 94.7 | |
| 7. Which of the following is a risk factor for prediabetes | Age over 40 | 17 | 9.0 |
| BMI of 20 | 4 | 2.1 | |
| Family history of type 2 diabetes* mellitus | 155 | 82.0 | |
| No answer | 13 | 6.9 | |
| 8. (USPSTF1) recommends screening adults for abnormal glucose if they are: | Age 40 to 70 and overweight or obese* | 59 | 31.2 |
| No answer | 23 | 12.2 | |
| Over the age of 45 and have at least one additional risk factor for abnormal glucose | 66 | 34.9 | |
| Overweight and obese at any age | 41 | 21.7 |
*Stands for the correct response. 1United States Preventive Services Task Force (USPSTF) current guideline
The distribution of study participants by their attitude towards prediabetes (n=189)
| Variable | Responses |
| % |
|---|---|---|---|
| 1. The national guidelines and recommendations for diabetes prevention focused on screening for prediabetes are useful in my practice | Agree | 115 | 60.8 |
| Disagree | 4 | 2.1 | |
| Neutral | 41 | 21.7 | |
| Strongly agree | 25 | 13.2 | |
| Strongly disagree | 4 | 2.1 | |
| 2. Diabetes prevention should be focused on individuals with lab values indicating abnormal blood glucose consistent with prediabetes | Agree | 104 | 55 |
| Disagree | 29 | 15.3 | |
| Neutral | 38 | 20.1 | |
| Strongly agree | 9 | 4.8 | |
| Strongly disagree | 5 | 2.6 | |
| Strongly disagree | 4 | 2.1 | |
| 3. Diabetes prevention should be a focus for all patients, regardless of blood glucose levels | Agree | 88 | 46.6 |
| Disagree | 31 | 16.4 | |
| Neutral | 43 | 22.8 | |
| Strongly agree | 24 | 12.7 | |
| Strongly disagree | 3 | 1.6 | |
| 4. Diagnosing a patient as being prediabetic is an effective way to increase patient awareness of their need for treatment. | Agree | 86 | 45.5 |
| Disagree | 7 | 3.7 | |
| Neutral | 28 | 14.8 | |
| Strongly agree | 66 | 34.9 | |
| Strongly disagree | 2 | 1.1 | |
| 5. Diagnosing prediabetes is misleading to patients regarding them having a disease. | Agree | 26 | 13.8 |
| Disagree | 103 | 54.5 | |
| Neutral | 36 | 19.0 | |
| Strongly agree | 4 | 2.1 | |
| Strongly disagree | 20 | 10.6 | |
| 6. Diagnosing a patient with prediabetes risks overtreatment. | Agree | 25 | 13.2 |
| Disagree | 109 | 57.7 | |
| Neutral | 34 | 18.0 | |
| Strongly disagree | 21 | 11.1 | |
| 7. Current evidence supports the utility of screening for prediabetes. | Agree | 107 | 56.6 |
| Disagree | 8 | 4.2 | |
| Neutral | 54 | 28.6 | |
| Strongly agree | 18 | 9.5 | |
| Strongly disagree | 2 | 1.1 | |
| 8. Current evidence supports the effectiveness of treating prediabetes. | Agree | 85 | 45.0 |
| Disagree | 4 | 2.1 | |
| Neutral | 80 | 42.3 | |
| Strongly agree | 19 | 10.1 | |
| Strongly disagree | 1 | 0.5 |
The distribution of study participants by their management practice towards prediabetes (n=189)
| Variable | Responses |
| % |
|---|---|---|---|
| 1. Most doctors do not consider screening for prediabetes to be a high priority in diabetes prevention. | agree | 43 | 22.8 |
| disagree | 66 | 34.9 | |
| neutral | 29 | 15.3 | |
| strongly agree | 9 | 4.8 | |
| strongly disagree | 42 | 22.2 | |
| 2. I give general lifestyle advice targeted toward reducing cardiovascular disease instead of advice specific to diabetes to patients with abnormal blood glucose. | agree | 52 | 27.5 |
| disagree | 61 | 32.3 | |
| neutral | 37 | 19.6 | |
| strongly agree | 28 | 14.8 | |
| strongly disagree | 11 | 5.8 | |
| 3. Most patients cannot successfully comply with lifestyle changes needed for diabetes prevention. | agree | 121 | 64.0 |
| disagree | 6 | 3.2 | |
| neutral | 41 | 21.7 | |
| strongly agree | 17 | 9.0 | |
| strongly disagree | 4 | 2.1 | |
| 4. I recommend metformin to most patients with prediabetes. | Agree | 73 | 38.7 |
| Disagree | 32 | 16.9 | |
| Neutral | 42 | 22.2 | |
| Strongly agree | 41 | 21.7 | |
| Strongly disagree | 1 | 0.5 | |
| 5. Primary lifestyle change stressed | Changing diet | 13 | 6.9 |
| Increasing the time of physical activity | 12 | 6.3 | |
| Stress all 3 equally | 144 | 76.2 | |
| Weight loss | 20 | 10.6 | |
| 6. Primary method of identifying someone at risk of developing diabetes | Asking about family history | 33 | 17.5 |
| Assessing Body Mass Index (BMI) | 30 | 15.9 | |
| Other | 11 | 5.8 | |
| Testing blood glucose concentrations | 115 | 60.8 | |
| 7. Do you offer counseling of diet control as preventive measure? | No | 4 | 2.1 |
| Yes | 185 | 97.9 | |
| 8. Do you discuss exercise as preventive measure? | No | 4 | 2.1 |
| Yes | 185 | 97.9 | |
| 9. Do you follow national guideline or screening recommendation? | No | 32 | 16.9 |
| Yes | 157 | 83.1 | |
| 10-Primary guideline followed | American Diabetes Association (ADA) | 41 | 21.7 |
| Don’t know | 21 | 11.1 | |
| Other/combination of guidelines | 20 | 10.6 | |
| United States Preventive Services Task Force (USPSTF) current guidelines | 107 | 56.6 |
The distribution of perceived barriers towards diabetes prevention to the study participants (n=189)
| Variables | Responses |
| % |
|---|---|---|---|
| 1. Medication compliance | A barrier | 96 | 50.8 |
| Extreme barrier | 19 | 10.1 | |
| Neutral | 27 | 14.3 | |
| Not a barrier | 4 | 2.1 | |
| Somewhat of a barrier | 43 | 22.8 | |
| 2. Patient acceptance of prediabetes diagnosis | A barrier | 71 | 37.6 |
| Extreme barrier | 33 | 17.5 | |
| Neutral | 28 | 14.8 | |
| Not a barrier | 14 | 7.4 | |
| Somewhat of a barrier | 43 | 22.8 | |
| 3. Insurance coverage of education for patient | A barrier | 79 | 41.8 |
| Extreme barrier | 26 | 13.8 | |
| Neutral | 34 | 18.0 | |
| Not a barrier | 23 | 12.2 | |
| Somewhat of a barrier | 27 | 14.3 | |
| 4. Patient ability to modify lifestyle | A barrier | 91 | 48.1 |
| Extreme barrier | 27 | 14.3 | |
| Neutral | 19 | 10.1 | |
| Not a barrier | 5 | 2.6 | |
| Somewhat of a barrier | 47 | 24.9 | |
| 5. Time needed to educate patient on diet and lifestyle change | A barrier | 45 | 23.8 |
| Extreme barrier | 13 | 6.9 | |
| Neutral | 27 | 14.3 | |
| Not a barrier | 25 | 13.2 | |
| Somewhat of a barrier | 79 | 41.8 | |
| 6. Insurance coverage for glucometers for patients | A barrier | 52 | 27.5 |
| Extreme barrier | 71 | 37.6 | |
| Neutral | 30 | 15.9 | |
| Not a barrier | 7 | 3.7 | |
| Somewhat of a barrier | 29 | 15.3 | |
| 7. Economic resources of patients | A barrier | 65 | 34.4 |
| Extreme barrier | 57 | 30.2 | |
| Neutral | 30 | 15.9 | |
| Not a barrier | 3 | 1.6 | |
| Somewhat of a barrier | 34 | 18.0 | |
| 8. Sustaining patient motivation | A barrier | 28 | 14.8 |
| Extreme barrier | 14 | 7.4 | |
| Neutral | 9 | 4.8 | |
| Not a barrier | 69 | 36.5 | |
| Somewhat of a barrier | 8 | 4.2 | |
| 61 | 32.3 | ||
| 9. Time for patient follow-up | A barrier | 47 | 24.9 |
| Extreme barrier | 6 | 3.2 | |
| Neutral | 41 | 21.7 | |
| Not a barrier | 21 | 11.1 | |
| Somewhat of a barrier | 74 | 39.2 | |
| 10. Knowledge of treatment options for prediabetes | A barrier | 34 | 18.0 |
| Extreme barrier | 6 | 3.2 | |
| Neutral | 49 | 25.9 | |
| Not a barrier | 58 | 30.7 | |
| Somewhat of a barrier | 42 | 22.2 |
Logistic regression analysis
| Variables |
| OR | 95% CI OR | |
|---|---|---|---|---|
|
| ||||
| Lower | Upper | |||
| Age | 0.159 | 1.070 | 0.974 | 1.175 |
| Gender | 0.326 | 1.551 | 0.646 | 3.726 |
| Duration of experience | 0.296 | 1.061 | 0.949 | 1.186 |
| Working hrs. per day | 0.121 | 0.882 | 0.753 | 1.034 |
| Patients seen per day | 0.537 | 1.007 | 0.985 | 1.030 |
| Attending relevant courses dealing with prediabetes | 0.033 | 2.082 | 1.063 | 4.079 |